Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for neutrophilic airway disease in asthma or COPD
ACTRN12609000259246Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and chronic obstructive pulmonary disease (COPD) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Interleukin-8 concentration in sputum supernatant. Started Jun 2009; status: completed.
02
Drugs
azithromycin
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12609000259246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000259246.